SCHEMBL20005765

SCHEMBL20005765

C#CCOc1ccc(C)cc1OCC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.54
KMT2A Q03164 2/20 0.50
MAPT P10636 6/20 0.49
L3MBTL1 Q9Y468 4/20 0.49
RAB9A P51151 2/20 0.49
ATM Q13315 1/20 0.49
HPGD P15428 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
AR P10275 1/20 0.42
ALDH1A1 P00352 2/20 0.42
POLB P06746 2/20 0.42
KDM4E B2RXH2 1/20 0.41
MAOA P21397 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 2/20 0.40
TP53 P04637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 1/20 0.39
PDE4B Q07343 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL805356 0.85 MAPT (0.61) KMT2AMAPTL3MBTL1RAB9AATM
SCHEMBL14384153 0.84 ACHE (0.59) MAOBKMT2AMAPTL3MBTL1RAB9A
SCHEMBL15146353 0.81 L3MBTL1 (0.50) MAOBKMT2AMAPTL3MBTL1RAB9A
SCHEMBL25528508 0.80 SMN1; SMN2 (0.45) MAOBKMT2AMAPTL3MBTL1RAB9A
SCHEMBL21356749 0.80 TSHR (0.49) MAPTL3MBTL1RAB9AHPGDTDP1
SCHEMBL8195926 0.80 MAOB (0.50) MAOBKMT2AMAPTL3MBTL1TDP1
SCHEMBL26650852 0.79 ALOX15 (0.44) MAOBKMT2AMAPTL3MBTL1HPGD
SCHEMBL16502112 0.77 MAPT (0.61) KMT2AMAPTL3MBTL1RAB9AATM
SCHEMBL7634998 0.76 ACHE (0.68) KMT2AMAPTL3MBTL1RAB9AATM
SCHEMBL7903433 0.76 ACHE (0.68) KMT2AMAPTL3MBTL1RAB9AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 MAOB 4088/4885KMT2A 470/4885MAPT 3938/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 MAOB 4088/4885KMT2A 470/4885MAPT 3938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.